VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Cov19VaxKB
Host Responses
VaximmutorDB
VIGET
Vaxafe
Vaxar
Vaxism
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign2
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UM Logo
Pathogen Page
Cancer

Table of Contents

  1. General Information
    1. Disease
    2. Introduction
  2. Vaccine Related Pathogen Genes
    1. 7299
    2. AAV2gp02
    3. ABALON
    4. ABL2
    5. ACP3
    6. ACPP
    7. ADAM17
    8. AFP
    9. AFP from human-Obsolete
    10. ag85A
    11. AIM2
    12. AKAP4
    13. AKT1
    14. ALDH1A1
    15. ALDH2
    16. ANTXR1
    17. AR
    18. asdfaf asf
    19. ASTE1
    20. ATL1
    21. B4GALNT1
    22. BCAP31
    23. BCL2L1
    24. CA9
    25. CCL21
    26. Ccl21a
    27. CCNG1
    28. CCNI
    29. CCR5
    30. CCR7
    31. CD19
    32. CD1D
    33. CD22
    34. CD33
    35. CD38
    36. CD3D
    37. CD40
    38. Cd40lg
    39. CD40LG
    40. CD44
    41. CD55
    42. CD58
    43. CD70
    44. Cd80
    45. CD80
    46. Cd86
    47. CD86
    48. CD8A
    49. CD90
    50. CDH3
    51. CDK1
    52. cdsR
    53. Cea-Mouse
    54. CEACAM1
    55. CEACAM3
    56. CEACAM5 (CEA)
    57. CEACAM5 - obsolete
    58. CHI3L1
    59. CLEC3B
    60. CLEC4C
    61. CRY2
    62. CSF1R
    63. Csf2-Mouse
    64. CSH1
    65. CTAG1B
    66. CTAG2
    67. CTLA4
    68. cupB5
    69. CYP1B1
    70. DCT
    71. DCT
    72. DDR1
    73. DEPDC1
    74. DItox
    75. E1B
    76. E2A
    77. E6
    78. E7
    79. EBNA-1
    80. EGFR
    81. Emb
    82. Eng
    83. ENG
    84. env
    85. EPCAM
    86. EPHA2
    87. ERBB2
    88. Erbb2
    89. EWSR1
    90. Fasl
    91. FASLG
    92. FCY1
    93. FGF2
    94. FGF5
    95. FIM3
    96. FL1
    97. FLT1
    98. Flt3
    99. FLT3LG
    100. FOLH1
    101. FOLR1
    102. Fosl1
    103. FOXO1
    104. Fragment C from tetanus toxin
    105. FUS
    106. GAA
    107. GALC
    108. Gla
    109. GLIPR1
    110. GM-CSF
    111. GM-CSF (human)
    112. GM-CSF (Mus musculus)
    113. GM2A
    114. GNRH1
    115. Gnrh1
    116. gp100 (PMEL)
    117. gp160
    118. gp72
    119. GPC3
    120. GPR183
    121. GPT
    122. GRDX
    123. GRIN1
    124. GRP
    125. GUCY2C
    126. H2-K1
    127. HA
    128. HBB
    129. HBsAg
    130. HER2-Dupli
    131. HLA-A
    132. HLA-B
    133. HLA-DRB1
    134. HPV6 E6
    135. HPV6 E6
    136. HRAS
    137. HSP47
    138. HSP90B1
    139. HSPA4
    140. HSPD1
    141. HuD
    142. human TP53 (P53)
    143. HUMGP 75
    144. ICAM1
    145. ID1
    146. IDH1
    147. IDO1
    148. IFNA2
    149. IFNB1
    150. IFNG
    151. IFNG- Obsolete
    152. IFNL3
    153. IGF2BP3
    154. IGFBP1
    155. IgG Fc
    156. IGHG1
    157. IL12
    158. IL12A
    159. IL12B
    160. IL13RA2
    161. Il18
    162. IL2
    163. IL2-Duplicate
    164. IL24
    165. IL3RA
    166. Immunoglobulin
    167. ITGB8
    168. ITIH4
    169. JUP
    170. KDR
    171. Kdr
    172. KIF20B
    173. KLK3
    174. KLK3-Dupli
    175. KRAS
    176. KRAS
    177. L1
    178. lacZ
    179. LADD-Ag
    180. LILRA2
    181. LMP-1
    182. LMP-2A
    183. LV28_RS26095 transcriptional regulator RegF
    184. LY6K
    185. MAGE-1
    186. MAGEA1 (MAGE1)
    187. MAGEA1-Duplicate
    188. MAGEA10
    189. MAGEA2
    190. MAGEA3
    191. MAGEA6
    192. MAGEA9
    193. MAGEC1
    194. MAGEC2
    195. major capsid protein L1
    196. MBL2
    197. Mcam
    198. MDM2
    199. MFGE8
    200. MGMT
    201. Mice Gene
    202. MLANA
    203. MLANA-Dupli
    204. mouse Trp53
    205. MOV10
    206. MS4A1
    207. MSLN
    208. MUC1
    209. Muc1
    210. MUC16
    211. MUC2
    212. MUC5B
    213. NF2
    214. NRAS
    215. NRP1
    216. NSCLC
    217. NUF2
    218. NY-ESO-1
    219. ny-eso-1
    220. ORF68
    221. P10
    222. PAEP
    223. PAGR1
    224. PAP
    225. Pap antigen
    226. PAX3
    227. PDCD1
    228. Pdgfrb
    229. PMEL - OBSOLETE
    230. PMEL - obsolete
    231. Pmel17
    232. pp65
    233. PRAME
    234. Prn
    235. PROM1
    236. Prostate specific antigen
    237. Prostate stem cell antigen
    238. Prostate-specific membrane antigen
    239. Prostate-specific membrane antigen
    240. PSMB9
    241. PTPRC
    242. PTTG1
    243. RANBP2
    244. RHD
    245. RNF43
    246. ROPN1
    247. Rpsa
    248. RUNX1
    249. S
    250. S100A6
    251. S100A9
    252. SCFV
    253. SCGB2A2
    254. SDC1
    255. SDC1-Obsolete
    256. sialyl-Tn
    257. SILV
    258. SLAMF7
    259. SLC5A5
    260. SOX2
    261. SOX6
    262. SPA17
    263. SPANXB1
    264. SPBC17D11.03c hypothetical protein
    265. SPY-1
    266. ST8SIA1
    267. Steap1
    268. STEAP1
    269. Survivin
    270. Survivin
    271. TAF1B
    272. TARP
    273. TBXT
    274. TERT
    275. TET1
    276. tetX
    277. TF
    278. TGFB2
    279. Th
    280. TLR4
    281. TLR7
    282. TLR9
    283. TMEM37
    284. TNF
    285. tnf-alpha
    286. TNFRSF18
    287. TNFSF10
    288. TNFSF18
    289. TOMM34
    290. TOP2A
    291. tox1
    292. TP53 - delete
    293. TPBG
    294. TRP-1
    295. TRP-2
    296. Trp2
    297. TRPC1
    298. Tumor Associated Antigen
    299. Tyrosinase
    300. Tyrosinase from Mouse
    301. TYRP1
    302. Tyrp1
    303. Ubiquitin
    304. UL122
    305. UL123
    306. UL83
    307. UL83
    308. UL97
    309. VEGFA
    310. VHL
    311. WHcAg
    312. WT1
    313. Xbp1
    314. XBP1
    315. Xcl1
    316. XCL1
    317. YBX1
  3. Vaccine Information
    1. (H115D)VHL35 Peptide Vaccine
    2. 1(SOCS1)-silenced dentritic cell (DC) vaccines
    3. 117-126:FGF-5 Peptide
    4. 12MP
    5. 12MP, 12MP/Tet, 12MP/6MHP, or 6MHP
    6. 27-35(27L):MART-1 peptide vaccine
    7. 4-peptide melanoma vaccine
    8. 851B Gel
    9. A2/4-1BBL melanoma vaccine
    10. Abagovomab
    11. Ad CMV I kappaB alpha
    12. Ad-sig-hMUC-1/ecdCD40L Vaccine
    13. Ad5-yCD/mutTKSR39rep-hIL12
    14. Ad5F35-LMP1/LMP2-Transduced Autologous Dendritic Cells
    15. Adenovector Encoding MDA7
    16. Adenovector-transduced AP1903-inducible MyD88/CD40-expressing Autologous PSMA-specific Prostate Cancer Vaccine BPX-201
    17. Adenoviral Vector Ad5-CEA(6D) Vaccine
    18. Adenovirus 5-CD40 Ligand
    19. Adenovirus 5-Fibroblast Growth Factor 2
    20. Adenovirus 5-Human Guanylyl Cyclase C-PADRE Vaccine
    21. Adenovirus B7-1
    22. Adenovirus Encoding Rat HER-2/neu
    23. Adenovirus Encoding Tyrosinase/MART-1/MAGEA6-transduced Autologous Dendritic Cell Vaccine
    24. Adenovirus HER2-Transduced Autologous Dendritic Cell Vaccine
    25. Adenovirus RSV-TK
    26. Adenovirus-mediated Human Interleukin-12
    27. Adenovirus-p53 Transduced Dendritic Cell Vaccine
    28. Adenovirus-PSA Prostate Cancer Vaccine
    29. adenovirus-transfected autologous DC vaccine plus CIK cells
    30. Adenovirus-vectored therapeutic vaccine (Ad-Ii-E1E2E6E7)
    31. AdRTVP-1-Transduced Prostate Cancer Cell-Based Vaccine
    32. AE37 Peptide/GM-CSF Vaccine
    33. AFP Gene Hepatocellular Carcinoma Vaccine
    34. Ag NY-ESO-1
    35. AGS-003-BLD Vaccine
    36. AIM2(-1)/HT001(-1)/TAF1B(-1) Frameshift Peptide Vaccine
    37. Algenpantucel-L
    38. ALK peptide vaccine
    39. Allogeneic AML Antigen-expressing Dendritic Cell Vaccine
    40. Allogeneic B7.1/HLA-A1 Transfected Tumor Cell Vaccine
    41. Allogeneic Cellular Vaccine 1650-G
    42. Allogeneic Dendritic Cell Vaccine COMBIG-DC
    43. Allogeneic Dendritic Cell-Myeloma Idiotype Vaccine
    44. Allogeneic Glioblastoma Stem-like Cell Line Lysate-pulsed Autologous Dendritic Cell Vaccine
    45. Allogeneic GM-CSF-Based Myeloma Cell Vaccine
    46. Allogeneic GM-CSF-Secreting Breast Cancer Vaccine
    47. Allogeneic GM-CSF-secreting Lethally Irradiated Pancreatic Tumor Cell Vaccine
    48. Allogeneic GM-CSF-secreting Tumor Vaccine PANC 10.05 pcDNA-1/GM-Neo
    49. Allogeneic GM-CSF-secreting Tumor Vaccine PANC 6.03 pcDNA-1/GM-Neo
    50. Allogeneic HLA-A2/4-1BB ligand-expressing Melanoma Vaccine
    51. Allogeneic Large Multivalent Immunogen Breast Cancer Vaccine
    52. Allogeneic Large Multivalent Immunogen Melanoma Vaccine LP2307
    53. Allogeneic Melanoma Vaccine AGI-101H
    54. Allogeneic Mesothelioma Tumor Lysate-pulsed Autologous Dendritic Cell Vaccine
    55. Allogeneic Multipotent Adult Progenitor Cells
    56. Allogeneic Renal Cell Carcinoma Vaccine MGN1601
    57. Allogeneic Tumor Cell Vaccine
    58. Allogenic Glioma Cancer Vaccine
    59. Alpha Fetoprotein Adenoviral Vector Vaccine
    60. Alpha Fetoprotein Plasmid DNA Vaccine
    61. Alpha-1,3-galactosyltransferase-expressing Allogeneic Renal Cell Carcinoma Vaccine
    62. Alpha-fetoprotein Peptide-Pulsed Autologous Dendritic Cell Vaccine
    63. Alpha-Galactosylceramide-Pulsed Autologous Dendritic Cells
    64. Alpha-type-1 Polarized Dendritic Cells
    65. ALVAC gp100 Vaccine
    66. ALVAC Vaccine
    67. ALVAC(2) Melanoma Multi-antigen Vaccine
    68. ALVAC(2)-NY-ESO-1 (M)/TRICOM Vaccine
    69. ALVAC-B7-CEA
    70. ALVAC-CEA (6D)-B7.1 Vaccine
    71. ALVAC-CEA (VCP248)
    72. ALVAC-CEA B7.1 Vaccine
    73. ALVAC-CEA Vaccine
    74. ALVAC-ESO-1 Vaccine
    75. ALVAC-hB7.1
    76. ALVAC-MART-1 Vaccine
    77. ALVAC-P53 Vaccine
    78. AMHR2-ED
    79. AML mRNA Positive Lysate Loaded Autologous Dendritic Cell Vaccine
    80. Amolimogene Bepiplasmid
    81. Androgen Receptor Ligand-binding Domain-encoding Plasmid DNA Vaccine MVI-118
    82. Ankara (MVA) and ALVAC(2) Vaccine
    83. Ankara (MVA) Vaccine
    84. Anti-CD19/CD3 Tetravalent Antibody AFM11 Vaccine
    85. Anti-CD3 x Anti-CD20 Bispecific Antibody-Armed Activated T Cells Cancer Vaccine
    86. Anti-CEA TCR Retroviral Vector-Transduced Autologous Peripheral Blood Lymphocytes
    87. Anti-CTLA4 MoAb RNA-transfected Autologous Dendritic Cell Vaccine
    88. Anti-CTLA4 MoAb RNA/GITRL RNA-transfected Autologous Dendritic Cell Vaccine
    89. Anti-GnRH Vaccine PEP223
    90. Anti-HER2/HER3 Dendritic Cell Vaccine
    91. Anti-idiotype MUC-1 Monoclonal Antibody Vaccine
    92. Anti-Idiotype Specified Monoclonal Antibody
    93. anti-idiotypic (anti-id) mAb MK2-23 + BCG
    94. Anti-idiotypic Monoclonal Antibody BEC2 Vaccine
    95. Anti-NY-ESO-1 Immunotherapeutic GSK-2241658A
    96. Anti-NY-ESO1 TCR-transduced Autologous CD62L+-derived T-Lymphocytes
    97. Anti-p53 T-Cell Receptor-Transduced Peripheral Blood Lymphocytes Vaccine
    98. Anti-PRAME Immunotherapeutic GSK2302032A Vaccine
    99. Antigen-CPP vaccine
    100. Antigen-targeted Personalized Breast Cancer Vaccine
    101. APC8015F
    102. Apoptotic Autologous Tumor Cells-pulsed Alpha-type-1 Polarized Dendritic Cells
    103. attenuated Listeria expressing cancer antigen vaccine
    104. AUT-OV-ALVAC-hB7.1 Vaccine
    105. Autolgous DC Vaccine Pulsed with Autologous Tumor Homogenate for Metastatic RCC
    106. Autologous Ad-CD154-Transduced CLL B Cells
    107. Autologous Anti-gp100:154-162 T-Cell Receptor Gene-Engineered Peripheral Blood Lymphocytes
    108. Autologous Anti-MART-1 F5 T-Cell Receptor Gene-Engineered Peripheral Blood Lymphocytes
    109. Autologous Cancer Testis Antigen Specific Dendritic Cell Vaccine
    110. Autologous CD133-Positive BTSC mRNA-Pulsed Autologous Dendritic Cell Vaccine
    111. Autologous CD40L-expressing B-CLL Vaccine
    112. Autologous CLL Tumor Cell Vaccine
    113. Autologous CMV-pp65-flLAMP mRNA Loaded Dendritic Cell Vaccine
    114. Autologous Colorectal Tumor Antigen-pulsed Dendritic Cell Vaccine
    115. Autologous CT7/MAGE-A3/WT1 mRNA-Electroporated Langerhans-Type Dendritic Cells
    116. autologous dendritic cell vaccine (DCV)
    117. Autologous Dendritic Cell Vaccine ACT2001
    118. Autologous dendritic cell vaccine loaded with personalized peptides (PEP-DC vaccine)
    119. Autologous Dendritic Cell-Adenovirus CCL21 Vaccine
    120. Autologous Dendritic Cell-Adenovirus P53 Vaccine
    121. Autologous Dendritic Cell-Allogeneic Melanoma Tumor Cell Lysate Vaccine
    122. Autologous Dendritic Cell-Autologous Tumor mRNA-Human CD40L Vaccine
    123. Autologous Dendritic Cell-based Immunotherapeutic AV0113
    124. Autologous Dendritic Cell-Tumor Fusion Vaccine
    125. autologous dendritic cells (DCs)
    126. Autologous Dinitrophenyl Vaccine
    127. Autologous Dinitrophenyl-Modified Ovarian Cancer Vaccine
    128. Autologous EBV-Transformed B Lymphoblastoid-Tumor Fusion Cell Vaccine
    129. Autologous Epstein-Barr Virus-Transformed B-Lymphoblastoid Cell Vaccine
    130. Autologous Expanded Mesenchymal Stem Cells OTI-010
    131. Autologous GM-CSF-Secreting Breast Cancer Vaccine
    132. Autologous GM-CSF-secreting Lethally Irradiated Colorectal Cancer Cell Vaccine
    133. Autologous GM-CSF-Secreting Lethally Irradiated Leukemia Cell Vaccine
    134. Autologous Heat-Shock Protein 70 Peptide Vaccine AG-858
    135. Autologous HNSCC DNA-transfected Semi-allogeneic Fibroblasts MRC-5 Vaccine
    136. Autologous IL-2-expressing B-CLL Vaccine
    137. Autologous Immunoglobulin Idiotype-KLH Conjugate Vaccine
    138. Autologous Lymphoma Cell Lysate-Pulsed Autologous Dendritic Cell Vaccine
    139. Autologous Lymphoma Cell/Allogeneic Dendritic Cell Electrofusion Hybrid Vaccine
    140. Autologous Lymphoma Cell/Autologous Dendritic Cell Electrofusion Hybrid Vaccine
    141. Autologous Lymphoma Immunoglobulin-derived scFv-chemokine DNA Vaccine
    142. Autologous Melanoma Lysate-Pulsed Autologous Dendritic Cell Vaccine
    143. Autologous Melanoma Lysate/KLH-Pulsed Autologous Dendritic Cell Vaccine
    144. Autologous Melanoma Lysate/NY-ESO-1-pulsed Autologous Dendritic Cell Vaccine
    145. Autologous monocyte-derived mature DCs pulsed with p53, survivin and telomerase-derived peptides
    146. Autologous Neuroblastoma Vaccine
    147. Autologous NSCLC DNA-Transfected Semi-Allogeneic Fibroblasts MRC-5 Vaccine
    148. Autologous NSCLC Peptide-specific Dendritic Cell Vaccine
    149. Autologous OFA-iLRP RNA-Transfected Dendritic Cell Vaccine
    150. Autologous Ovarian Tumor Cell Lysate-Pulsed Dendritic Cell Vaccine
    151. Autologous Oxidized Ovarian Tumor Cell Lysate Vaccine
    152. Autologous Pluripotent ALDHbr Stem Cells ALD-451
    153. Autologous Prostate Cancer Antigen-expressing Dendritic Cell Vaccine BPX-101
    154. Autologous Renal Cell Carcinoma Tumor Lysate-Pulsed Dendritic Cell Vaccine
    155. Autologous Sarcoma Lysate-pulsed Dendritic Cell Vaccine
    156. Autologous TARP Peptide-Pulsed Dendritic Cell Vaccine
    157. Autologous Total Tumor mRNA and CMV-pp65-flLAMP mRNA Loaded Liposome Vaccine
    158. Autologous TriMix-DC Melanoma Vaccine
    159. Autologous tumor cell lysate vaccine
    160. Autologous Tumor Cell Proteoliposome Chronic Lymphocytic Leukemia Vaccine
    161. Autologous Tumor Cell Vaccine
    162. Autologous Tumor-associated Peptide Antigen-pulsed Dendritic Cell Vaccine
    163. Autologous, DNP-Modified Ovarian Cancer Vaccine
    164. Autologous-Cell Leukemia Vaccine
    165. Autologous-Cell Melanoma Vaccine
    166. B-cell lymphoma DNA vaccine VCL-1642.XXX encoding a chimeric immunoglobulin molecule onsisting of tumor-specific variable (Id) regions
    167. B16 melanoma DNA vaccine pCMV-hTRP-1 encoding TRP-1
    168. B16 melanoma DNA vaccine pSin-hTRP-1 encoding TRP-1
    169. B16 melanoma DNA vaccine pSin-mTRP-1
    170. B16 Vaccine adjuvanted by Loxoribine
    171. B7.1/​IL-2 Leukaemia Cell Vaccine
    172. Bacille Calmette Guérin for melanoma of lower extremity
    173. Bacillus Calmette-Guerin (BCG)
    174. Bacillus Calmette-Guerin (BCG), C. parvum
    175. Bacillus Calmette-Guerin (BCG), dinitrochlorobenzene (DNCB)
    176. bacillus Calmette-Guerin (MER)
    177. BC-819
    178. BCG
    179. BCG and chemotherapy for malignant melanoma
    180. BCG and Corynebacterium parvum for malignant melanoma
    181. BCG treatment after surgical tumor removal
    182. BCG, Cell Wall Skeleton
    183. Bcl-Xl_42-CAF09b Vaccine
    184. Bcl-Xs Adenovirus Vaccine
    185. Bcr-Abl (b2a2)-Derived Peptide Vaccine
    186. Bcr-Abl (b3a2)-Derived Peptide Vaccine
    187. Bcr-abl peptide vaccine
    188. Belagenpumatucel-L
    189. Berzofsky Ras/P53 Peptide Vaccine
    190. Biolistic DNA vaccination
    191. Bivalent Vaccine with Adjuvant OPT-821
    192. Brachyury-expressing Modified Vaccinia Ankara-TRICOM Vaccine
    193. Brain Tumor Initiating Cell Vaccine
    194. C29561
    195. Canarypox-hIL-12 Melanoma Vaccine
    196. Cancer DNA Vaccine encoding Endoglin Boosted with Recombinant Endoglin Protein
    197. Cancer DNA Vaccine encoding TEM8
    198. Cancer DNA Vaccine MIDGE/hNIS encoding hNIS protein
    199. Cancer DNA vaccine p.DOM-AH1 encoding fragment C
    200. Cancer DNA Vaccine pLXSHDmB7-2 encoding Cd86
    201. Cancer DNA Vaccine pSURV encoding Survivin
    202. Cancer EPCAM protein vaccine
    203. Cancer Her-2/neu Protein Subunit Vaccine
    204. Cancer recombinant vector vaccine encoding H-2Kb
    205. Cancer Retroviral Vector Vaccine encoding Cd40lg
    206. Cancer Stem Cell DC Vaccine
    207. Cancer Subunit DC (Tat-CEA) vaccine
    208. Cancer Subunit GV1001 Protein Vaccine
    209. Cancer Subunit NY-ESO-1 Protein Vaccine
    210. Cancer Vaccine using E7 protein of human papillomavirus 16 and Algammulin
    211. Cancer Vaccine using E7 protein of human papillomavirus 16 and Quil-A
    212. Cancer VEGFA protein vaccine
    213. Canvaxin
    214. CAP-2 (CEA Peptide 9-mer)
    215. CAP-3 (CEA Peptide 9-mer)
    216. CAR G36-PDL1
    217. Carcinoembryonic Antigen Peptide 1-6D
    218. Carcinoembryonic Antigen Peptide 1-6D Virus-Like Replicon Particles Vaccine
    219. Carcinoembryonic Antigen Peptide-1 Vaccine
    220. Carcinoembryonic Antigen RNA-pulsed DC Cancer Vaccine
    221. Carcinoma DNA vaccine pVAX/E2A
    222. CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine
    223. CD133 Antigen Peptide-pulsed Autologous Dendritic Cell Vaccine
    224. CD80 Breast Cancer Vaccine
    225. CDX-1307 Vaccine
    226. CEA RNA-pulsed Autologous Human Cultured Dendritic Cells
    227. CEA/Tetanus Toxoid T Helper Epitope Fusion Protein-Expressing DNA Plasmid Vaccine
    228. Chimeric Ad11p/Ad3 Oncolytic Virus
    229. Chimeric exosomal tumor vaccine
    230. Class I HLA-A*0201-restricted gp100209-2M peptide vaccine
    231. CLL Idiotypic DNA Vaccine
    232. CMV pp65 Peptide-pulsed Autologous Dendritic Cell Vaccine
    233. CMVpp65/gB Plasmid Vaccine ASP0113
    234. Colorectal cancer DNA vaccine pCEA/HBsAg encoding carcinoembryonic antigen and hepatitis B surface antigen
    235. Contusugene ladenovec
    236. Corynebacterium parvum, DTIC
    237. CpG 7909/PF3512676
    238. CTP-37-DT Vaccine
    239. CVB4/p24(73(3))
    240. Cyclin B1 Peptide-pulsed Autologous Dendritic Cell Vaccine
    241. Cyclin B1/WT-1/CEF-Loaded DC Vaccine
    242. Cytokine-Induced Killer Cells
    243. DC/AML Fusion Vaccine
    244. Dendritic Cell Survivin Vaccine
    245. Dendritic Cell Tumor Cell Lysate Vaccine
    246. Dendritic Cell Tumor Peptide Vaccine
    247. Dendritic Cell-Autologous Lung Tumor Vaccine
    248. Dendritic Cell-CEA Peptide Vaccine
    249. Dendritic Cell-gp100-MART-1 Antigen Vaccine
    250. Dendritic Cell-Idiotype-Keyhole Limpet Hemocyanin Vaccine
    251. Dendritic Cell-MART-1 Peptide Vaccine
    252. Dendritic Cell-Recombinant Prostate-Specific Membrane Antigen Vaccine
    253. Dendritic Cell-targeting Lentiviral Vector ID-LV305
    254. Dendritic Cell/​Myeloma Fusion Vaccine
    255. Dendritic vaccine, allogeneic hematopoietic stem cells, cytotoxic lymphocytes
    256. Dendritic vaccine, autologous hematopoietic stem cells, cytotoxic lymphocytes
    257. DEPDC1/MPHOSH1 Peptide Vaccine
    258. Dinitrophenyl-Modified Autologous Renal Cell Carcinoma Tumor cell Vaccine
    259. DIPG and GMB Immunomodulatory DC Vaccine
    260. DLK1/EPHA2/HBB/NRP1/RGS5/TEM1 Peptide-pulsed Alpha-type-1 Polarized Dendritic Cell Vaccine
    261. DNA Plasmid Encoding Interleukin-12 INO-9012
    262. DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112
    263. DNA Vaccine encoding p42.3
    264. DNA Vaccine VB10.16
    265. DNA Vector pPRA-PSM Vaccine
    266. DNP-modified autologous vaccine
    267. E1M(184V) Peptide Vaccine
    268. EF-1 Peptide Vaccine
    269. EF-2 Peptide Vaccine
    270. EGFRvIII Peptide Vaccine
    271. Electrofusion DC vaccine
    272. electroloading of mature dendritic cells with melanoma whole tumor cell lysate
    273. Emepepimut-S Vaccine
    274. EP-2101 Vaccine
    275. ESAT-6-gpi DNA vaccine combined with B16F10-ESAT-6-gpi/IL-21 vaccine
    276. ESO-1 (161-180) Peptide Vaccine
    277. ESO-1 Reactive Autologous Peripheral Blood Lymphocyte Vaccine
    278. ESO-1:157-165(165V) Peptide Vaccine
    279. ESR1 peptide vaccine
    280. Falimarev Vaccine
    281. Fas-Chimera Transgene-expressing Endothelial Tumor Cell-targeting Adenovector VB-111 Vaccine
    282. Flagrp170
    283. Folate-FITC Vaccine
    284. Follicular lymphoma, patient-specific, soluble protein idiotype vaccine
    285. Fowlpox Virus Vaccine
    286. Fowlpox Virus Vaccine Vector
    287. Fowlpox-NY-ESO-1 Vaccine
    288. Fowlpox-PSA-TRICOM Vaccine
    289. FRAME-001 personalized vaccine
    290. FrSh61 (MEA) VHL33 Peptide Vaccine
    291. FVAX
    292. G250 Peptide Vaccine
    293. Gag:267-274 Peptide Vaccine
    294. GD2-CAR
    295. GD2L, GD3L, Globo H, fucosyl GM1, and N-propionylated polysialic acid KLH Conjugate Vaccine
    296. Genetically Engineered Allogeneic Prostate Carinoma Cells Secreting Interleukin-2 and Interferon Gamma
    297. GITRL RNA-transfected Autologous Dendritic Cell Vaccine
    298. Glioma-Associated Antigen Peptide-Pulsed Autologous Dendritic Cell Vaccine
    299. Glioma-associated Peptide-loaded Dendritic Cell Vaccine SL-701
    300. Globo H-DT Vaccine OBI-833
    301. Globo H-GM2-Lewis-y-MUC1-32-mer-TF(c)-Tn(c)-KLH Conjugate Vaccine
    302. Globo-H-GM2-Lewis-y-MUC1-32(aa)-sTn(c)-TF(c)-Tn(c)-KLH Conjugate Vaccine
    303. Glypican-3-derived peptide vaccine for human hepatocellular carcinoma
    304. GM-CSF transfected cells vaccine
    305. GM-CSF, IL-12 and GM-CSF+IL-12 genetically modified tumor cell vaccine
    306. GM-CSF-encoding Oncolytic Adenovirus CGTG-102 Vaccine
    307. GM-K562 cell vaccine
    308. GM.CD40L Cell Vaccine
    309. GM2/GD2/GD3 Lactone-KLH Conjugate Trivalent Vaccine
    310. Golnerminogene Pradenovec Vaccine
    311. gp100 + Mart-1 + Mart-3 Vaccine
    312. gp100 Adenovirus Vaccine
    313. gp100 and GM-CSF DNA/Gold Vaccine
    314. gp100 mature dendritic cell vaccine
    315. gp100 Protein (184V) Vaccine
    316. gp100 Vaccine
    317. gp100 Vaccinia Vaccine
    318. gp100-Fowlpox Vaccine
    319. gp100-Pulsed Peripheral Blood Mononuclear Cell Vaccine
    320. gp100-Reactive Autologous Peripheral Blood Lymphocyte Vaccine
    321. gp100/IFA Vaccine
    322. gp100: ES209-217(210M) Peptide Vaccine
    323. gp100:154-162 Peptide Vaccine
    324. gp100:209-217 Peptide Vaccine
    325. gp100:209-217(210M) peptide vaccine
    326. gp100:280-288 Peptide Vaccine
    327. gp100:280-288(288V) Peptide Vaccine
    328. gp96-secreting Allogeneic Bladder Cancer Cell Vaccine HS-410
    329. GVAX Cancer Vaccine
    330. GVAX Leukemia Vaccine
    331. GVAX Lung Cancer Vaccine
    332. GVAX Pancreatic Cancer Vaccine
    333. H3.3K27M-specific Peptide Vaccine
    334. hapten dinitrophenyl
    335. HCA587 protein vaccine
    336. HCV DNA Vaccine INO-8000
    337. HER-2-neu, CEA peptides, GM-CSF, Montanide ISA-51 vaccine
    338. HER2 ECD+TM Virus-like Replicon Particles Vaccine AVX901
    339. HER2 ICD peptide vaccine
    340. HER2-pulsed Autologous Type-1 Polarized Dendritic Cell Vaccine
    341. Hexapeptide melanoma vaccine
    342. HLA Neoantigen Vaccine
    343. HLA-A*0201-Restricted TRP2-gp100-EphA2-HER2 multipeptide Vaccine
    344. HLA-A*0201-Restricted URLC10-VEGFR1-VEGFR2 Multipeptide Vaccine
    345. HLA-A*0201-Restricted VEGFR1 Peptide Vaccine
    346. HLA-A*2402-Restricted VEGFR1 Peptide Vaccine
    347. HLA-A*2402-Restricted VEGFR1/2 Multipeptide Vaccine
    348. HLA-A*2404-Restricted RNF43-TOMM34-VEGFR1-VEGFR2 Multipeptide Vaccine
    349. HLA-A1, A2, B35-Restricted Survivin Peptides/Montanide ISA-51 Vaccine
    350. HLA-A1, HLA-A2, and CD40-Ligand Pulsed Dendritic Cell Vaccine
    351. HLA-A1-Binding MAGE-1/MAGE-3 Multipeptide-Pulsed Autologous Dendritic Cell Vaccine
    352. HLA-A2, A3-Restricted FGF-5 Peptides/Montanide ISA-51 Vaccine
    353. HLA-A2-Binding TYR/MART-1/gp100 Multipeptide-Pulsed Autologous Dendritic Cell Vaccine
    354. HLA-A2-Restricted Synthetic Glioma Antigen Peptides Vaccine
    355. HLA-Matched Donor Mononuclear Cell-Enriched Leukocytes Apocell Vaccine
    356. hMART-IT
    357. Hodgkin's antigens-GM-CSF-expressing cell vaccine
    358. Host Dendritic Cell Vaccine-001 MSSM/BIIR
    359. HPV 16 E6 (18-26) Peptide Vaccine
    360. HPV 16 E7:12-20 Peptide Vaccine
    361. HPV 16 E7:86-93 Peptide Vaccine
    362. HPV 16 L1-VLP Vaccine
    363. HPV 18 E6:13-21 Peptide Vaccine
    364. HPV 18 L1-VLP Vaccine
    365. HPV DNA Plasmids Therapeutic Vaccine VGX-3100
    366. HPV E6/E7 DNA Vaccine GX-188E
    367. HPV E6/E7-encoding Semliki Forest Virus Vaccine Vvax001
    368. HPV-11 Vaccine
    369. HPV-6-targeting Immunotherapeutic Vaccine INO-3106
    370. HPV16 E6/E7 Melanoma Vaccine
    371. HSP65-HER2 fusion peptide
    372. Hsp70 chaperone-based gel composition
    373. HSPPC-96
    374. hTERT I540/R572Y/D988Y Multipeptide Vaccine
    375. hTERT mRNA/Survivin Peptide-double-loaded Autologous Dendritic Cell Vaccine
    376. hTERT Multipeptide/Montanide ISA-51 VG/Imiquimod Vaccine GX 301
    377. hTERT Vaccine V934/V935
    378. hTERT-LAMP mRNA-loaded Autologous Dendritic Cell Vaccine GRNVAC1
    379. hTERT/Survivin/CMV Multipeptide Vaccine
    380. hTERT/Survivin/Melanoma Tumor Cell-Derived mRNA-Transfected Dendritic Cell Vaccine
    381. human leukocyte antigen class I-modified peptides
    382. Human Myeloid Progenitor Cells CLT-008 Vaccine
    383. Human Papilloma Virus L1 Virus-Like Particle V504 Vaccine
    384. Human Papillomavirus 16 E7 Peptide/Padre 965.10 Vaccine
    385. Human Papillomavirus 16/18 L1 Virus-Like Particle/AS04 Vaccine
    386. Human Papillomavirus Tumor Antigen Vaccine
    387. Human Papillomavirus Vaccine V503
    388. Human Prostate-Specific Membrane Antigen Plasmid DNA Vaccine
    389. HUVECs-OK432 vaccine
    390. hVEGF26-104/RFASE Peptide Vaccine
    391. HyperAcute - Breast cancer vaccine
    392. HyperAcute-Melanoma Vaccine
    393. HyperAcute-Prostate Cancer Vaccine
    394. ICT-121 Dendritic Cell Vaccine
    395. IDD-3
    396. IDH1R132H Mutation-targeting IDH1 Peptide Vaccine
    397. IDH1R132H-Specific Peptide Vaccine PEPIDH1M
    398. Idiotype-Pulsed Autologous Dendritic Cell Vaccine APC8020
    399. IDO peptide vaccine
    400. IFN/tremem
    401. IL-12-expressing Mesenchymal Stem Cell Vaccine GX-051
    402. IL-12p70
    403. IL-2, Peptide, and GM-CSF-in-adjuvant Melanoma Vaccine
    404. IL-2/Lptn Gene-Modified Allogeneic Neuroblastoma Tumor Cell Vaccine
    405. IL15-DC Vaccine
    406. IMM-101
    407. Immunotherapeutic GSK1572932A
    408. IMT-1012 Immunotherapeutic Vaccine
    409. Inactivated Vaccinia Virus
    410. Inalimarev Vaccine
    411. Incomplete Freund's adjuvant (IFA) alone, or a melanoma vaccine in IFA
    412. Indium In 111-Labeled Autologous Peripheral Blood Mononuclear Cells Vaccine
    413. Indium In 111-Labeled Autologous Polymorphonuclear Leukocytes Vaccine
    414. Indoleamine 2,3-dioxygenase Peptide Vaccine
    415. Interferon-gamma-expressing Adenovirus Vaccine ASN-002
    416. Interleukin-2 Anti-Idiotype Vaccine
    417. Intracel KLH Vaccine
    418. intralesional bacile Calmette-Guérin (BCG)
    419. intralesional bacile Calmette-Guérin (BCG), DTIC, vincristine
    420. Ipilimumab
    421. Ipilimumab
    422. ipilimumab, vemurafenib
    423. irradiated autologous cells
    424. irradiated melanoma cells plus BCG
    425. α-GalCer-loaded tumor-cell vaccine
    426. KLH and Tumor Lysate Pulsed DC Vaccine
    427. KLH-FITC Vaccine
    428. KLH-id Vaccine
    429. KLH-Lymphoma Ig Vaccine
    430. KLH-pulsed autologous dendritic cell vaccine
    431. KRAS-targeted mRNA vaccine
    432. KSA-KLH Conjugate Vaccine
    433. L612 HuMAb
    434. Lapuleucel-T Vaccine
    435. Large Multivalent Immunogen (LMI) vaccine
    436. Leukemic Apoptotic Corpse-Pulsed Autologous Dendritic Cells Vaccine
    437. Light-Emitting Oncolytic Vaccinia Virus GL-ONC1 Vaccine
    438. Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101
    439. Liposomal MUC1/PET-lipid A Vaccine
    440. Live-attenuated Double-deleted Listeria monocytogenes Bacteria JNJ-64041809
    441. Live-attenuated Double-deleted Listeria monocytogenes Bacteria JNJ-64041809 Vaccine
    442. Live-attenuated Listeria monocytogenes-encoding EGFRvIII-NY-ESO-1 Vaccine ADU-623
    443. LMP-2:340-349 Peptide Vaccine
    444. LMP-2:419-427 Peptide Vaccine
    445. LMP2A-loaded conventional DC vaccine
    446. Long Peptide Vaccine 7
    447. long-peptide vaccine and mAb
    448. Lung metastasis DNA vaccine pCEP4-MUC1 encoding MUC1
    449. LY6K/VEGFR1/VEGFR2 Multipeptide Vaccine
    450. Lymphoma DNA vaccine VαVβVβ-FrC
    451. mAb PC61 and DC/tumor fusion
    452. MAGE-1 Vaccinia Contaminated with BVDV
    453. MAGE-3.A1 Peptide Vaccine
    454. MAGE-A1, Her-2/neu, FBP peptides ovarian cancer vaccine
    455. MAGE-A1/MAGE-A3/NY-ESO-1 Peptides Vaccine
    456. MAGE-A12:170-178
    457. MAGE-A3 + AS15
    458. MAGE-A3 Peptide Vaccine
    459. MAGE-A3-expressing Adenovirus Type 5 Vaccine
    460. MAGE-A3-genetically modified lymphocytes
    461. MAGE-A3/HPV 16 Peptide Vaccine
    462. Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine
    463. Mammaglobin-A DNA Vaccine
    464. Maraba virus MG1 Vaccine
    465. MART-1
    466. MART-1 Adenovirus Vaccine
    467. MART-1 Fowlpox Vaccine
    468. MART-1 Vaccinia Vaccine
    469. MART-1, tyrosinase and MAGE-A6 Autologous DC Vaccine
    470. MART-1/gp100/Tyrosinase/MAGE-A3 Peptides-loaded Irradiated Allogeneic Plasmacytoid Dendritic Cells Vaccine
    471. MART-1:26-35(27L) Peptide Vaccine
    472. MART-1:27-35 Peptide Vaccine
    473. Mature dendritic cell melanoma vaccine
    474. MCMV-TRP2
    475. mCRT-vGPCR-coated whole-cell vaccine
    476. MDX-1379 (gp100) Melanoma Peptide Vaccine
    477. MDX-CTLA4 Antibody/Tyrosinase/gp100/MART-1 Melanoma Vaccine
    478. Melacine
    479. Melan-A VLP Vaccine
    480. Melan-A/MAGE-3.DP4 Peptide Vaccine
    481. Melan-A/Mart-1
    482. Melanoma DNA vaccine gp75 DNA encoding melanosomal membrane glycoproteins, gp75
    483. Melanoma DNA vaccine hTRP2 encoding TRP-2
    484. Melanoma DNA vaccine hugp100 encoding gp100
    485. Melanoma DNA vaccine pCR3.1-VS-HSP65-TP-GRP6-M2 encoding 6 tandem repeats of GRP
    486. Melanoma DNA vaccine pN4a-MAGE-1-GM
    487. Melanoma DNA vaccine pNL3-MAGE-1-GM
    488. Melanoma DNA vaccine pUB-TRP-2 encoding a fusion protein linking murine ubiquitin (UB) to the N-terminus of the full-length mTRP-2
    489. Melanoma DNA vaccine SINCp c-muMUC18 encoding MCAM/MUC18
    490. Melanoma DNA vaccine TA2Mâ„¢ encoding tyrosinase peptides
    491. Melanoma DNA vaccine VR-S8/VR-IL2/AD-S8 encoding survivin
    492. Melanoma DNA vaccine VR1012/mPmel17
    493. Melanoma DNA vaccine xenogeneic DNA encoding murine tyrosinase
    494. melanoma helper peptide vaccine
    495. Melanoma recombinant vector vaccine rVVmTRP-1 encoding TRP-1
    496. Melanoma Theraccine
    497. Melanoma-specific Melan-A/Mart-1 peptide + virus-like nanoparticles
    498. Melapuldencel-T Vaccine
    499. MELITAC 12.1 Peptide Vaccine
    500. Mesothelioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine
    501. Methanol Extraction Residue of BCG
    502. MG1-hDCT Vaccine
    503. MiHA-loaded PD-L1/L2-silenced Dendritic Cell Vaccine
    504. Mimotope-P10s-PADRE Peptide Vaccine
    505. Mixed bacterial vaccine
    506. Modified Vaccinia Ankara (Bavarian Nordic)-HER2 Vaccine
    507. Modified Vaccinia Virus Ankara Vaccine Expressing p53
    508. Monoclonal Antibody 105AD7 Anti-idiotype Vaccine
    509. Monoclonal Antibody 11D10 Anti-Idiotype Vaccine
    510. Monoclonal Antibody 3H1 Anti-Idiotype Vaccine
    511. Monoclonal Antibody 4B5 Anti-Idiotype Vaccine
    512. Monoclonal Antibody A1G4 Anti-Idiotype Vaccine
    513. Monoclonal Antibody GD2 Anti-Idiotype Vaccine
    514. Montanide ISA-51/Survivin Peptide Vaccine
    515. Mouse gp100 Plasmid DNA Vaccine
    516. Mouse Prostate-Specific Membrane Antigen Plasmid DNA Vaccine
    517. mouse/human gp10025-33 peptide plus CpG adjuvant; mouse/human gp100; mouse/human gp10025-33 peptide-pulsed DCs
    518. MOv-PBL Vaccine
    519. mRNA neoantigen tumor vaccine
    520. mRNA tumor antigen DC vaccine
    521. mRNA-based Personalized Cancer Vaccine NCI-4650
    522. mRNA-Derived Prostate Cancer Vaccine CV9103
    523. mRNA-electroporated dendritic cells encoding gp100 and tyrosinase as melanoma vaccine
    524. MSCV-MGMT(P140K) Vaccine
    525. MT-201-GBM monocyte vaccine
    526. MUC-1 Peptide Vaccine
    527. MUC-2-Globo H-KLH Conjugate Vaccine
    528. MUC-2-KLH Vaccine
    529. MUC1 Antigen/SB AS-2 Vaccine
    530. MUC1 Peptide-Poly-ICLC Vaccine
    531. MUC1-FSL-1-TT tricomponent vaccine
    532. MUC1-KLH Conjugate Vaccine
    533. MUC1-KLH Vaccine/QS21
    534. MUC1-targeted Peptide GO-203-2C Vaccine
    535. Multi-epitope Folate Receptor Alpha Peptide Vaccine
    536. Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine
    537. Multi-epitope HER2 Peptide Vaccine TPIV100
    538. Multi-epitope melanoma peptide vaccine
    539. Multi-glioblastoma-peptide-targeting Autologous Dendritic Cell Vaccine ICT-107
    540. Multi-peptide CMV-Modified Vaccinia Ankara Vaccine
    541. Multiantigen Liposome Loaded Dendritic Cell Vaccine
    542. Multipeptide melanoma vaccine
    543. Multipeptide Vaccine S-588210
    544. Multipeptide XS15 Vaccine
    545. Multiple Signals loaded Dendritic Cells Vaccine
    546. Multivalent immunotherapeutic vaccine
    547. Murine TYRP2 Plasmid DNA Vaccine
    548. Mutant p53 Peptide Pulsed Dendritic Cell Vaccine
    549. Mutated neopeptide vaccine
    550. MVA-BN-CV301
    551. MVA-EBNA1/LMP2 Vaccine
    552. MVA-FCU1 TG4023 Vaccine
    553. MVA-MUC1-IL2 Vaccine
    554. MVA-PSA/PAP Prostate Cancer Vaccine
    555. MVF-HER-2(597-626)/MVF-HER-2 (266-296) Peptide Vaccine
    556. MVF-HER-2(628-647)-CRL 1005 vaccine
    557. NA-17/MAGE-3.A2/NY-ESO-1 Peptide Vaccine
    558. NA17.A2 Peptide Vaccine
    559. Natural Killer Cells ZRx101 Vaccine
    560. Nelipepimut-S Plus GM-CSF Vaccine
    561. NEO-PV-01 vaccine
    562. Neoantigen DNA Vaccine
    563. Neoantigen Peptide Vaccine
    564. neoantigen synthetic long peptide vaccine
    565. Neoantigen-loaded Autologous Dendritic Cell Vaccine
    566. Neuroblastoma DNA vaccine HuDsec
    567. Newcastle disease virus lysate
    568. NY-ESO-1 Peptide Vaccine
    569. NY-ESO-1 Plasmid DNA Cancer Vaccine
    570. NY-ESO-1(157-165) Peptide-pulsed Autologous Dendritic Cell Vaccine
    571. NY-ESO-1, MAGE-A1, and MAGE-A3 Dendritic Cell Vaccine
    572. NY-ESO-1/GLA-SE Vaccine ID-G305AmN
    573. NY-ESO-1/LAGE-1 Peptide Vaccine
    574. NY-ESO-1/MART-1 Peptide-pulsed Dendritic Cell Vaccine
    575. NY-ESO-1/PRAME/MAGE-A3/WT-1 Peptide Vaccine
    576. NY-ESO-1b Peptide Vaccine
    577. NY-ESO-B Vaccine
    578. OCDC and NeoDC Vaccine
    579. Oncolytic Adenovirus Encoding GM-CSF Vaccine
    580. Oncovax-ID/IL-2 Vaccine
    581. ONYX-015 Vaccine
    582. Oral Bacille Calmette-Guérin for malignant melanoma
    583. Oral Cancer Vaccine V3-OVA
    584. Oral Therapeutic Vaccine V3-X
    585. OVA-TEXO
    586. Ovapuldencel-T Vaccine
    587. Ovarian Cancer Peptide Vaccine
    588. Ovarian Cancer Stem Cell/hTERT/Survivin mRNAs-loaded Autologous Dendritic Cell Vaccine
    589. Ovarian Tumor Antigen-activated Autologous Dendritic Cell Vaccine
    590. p.DOM-WT1-126 DNA Vaccine
    591. p.DOM-WT1-37 DNA Vaccine
    592. P30-linked EphA2/CMV pp65/Survivin Peptide Vaccine P30-EPS
    593. P501-AS15 vaccine
    594. p53 Peptide Vaccine
    595. P53-Synthetic Long Peptides Vaccine
    596. PA-1-STK Ovarian Carcinoma Vaccine
    597. PADRE-CMV Fusion Peptide Vaccine
    598. Pancreatic tumor personalized neoantigen vaccine
    599. PAX3/FKHR Peptide Vaccine
    600. pcDNA3-MCC/ST
    601. PCLUS 3-18MN Vaccine
    602. PCLUS 6.1-18MN Vaccine
    603. pCR3.1-VS-HSP65-TP-GRP6-M2
    604. PD-L1 peptide vaccine
    605. PD-L1/IDO Peptide Vaccine IO102-103
    606. PEP-3-KLH Conjugate Vaccine
    607. PEP-CMV Vaccine
    608. Personal neoantigen cancer vaccine
    609. Personalized follicular lymphoma vaccine
    610. Personalized mature dendritic cell vaccine
    611. Personalized NeoAntigen Melanoma Vaccine
    612. Personalized Synthetic Long Peptide Breast Cancer Vaccine
    613. Pexastimogene-devacirepvec Vaccine
    614. PF-04948568 Vaccine
    615. Plasmacytoid Dendritic Cell Vaccine
    616. pNGVL3-hICD Vaccine
    617. pNGVL4a-CRT/E7(detox) DNA Vaccine
    618. pNGVL4a-Sig/E7(detox)/HSP70 DNA Vaccine
    619. Poliovirus vector expressing model antigen H2-Kb-restricted CTL epitope
    620. Poly Microsphere Encapsulated HER2/neu Oral Vaccine
    621. PolyPEPI1018 CRC Vaccine
    622. Polyvalent melanoma vaccine
    623. PR-151 Peptide Vaccine
    624. PR1 Leukemia Peptide Vaccine
    625. Primary Prostate Cancer Tissue/hTERT/Survivin mRNA-loaded Autologous Dendritic Cell Vaccine
    626. prime/boost DC-TRP-2 melanoma vaccine
    627. procarbazine, dactinomycin, velba
    628. Prodencel
    629. Prostate cancer DNA vaccine encoding PSCA
    630. Prostate cancer DNA vaccine hPSMAt encoding PSMA
    631. Prostate cancer DNA vaccine pcDNA3-STEAP encoding six-transmembrane epithelial antigen
    632. Prostate cancer DNA vaccine pDOM-PSMA27 encoding PSMA
    633. Prostate cancer DNA vaccine pmPSCA encoding PSCA
    634. Prostate cancer DNA vaccine PSCA-HSP encoding PSCA and HSP
    635. Prostate cancer DNA vaccine psig-3P-Fc encoding 3P(hPSM, hPAP, or hPSA)-Fc fusion protein
    636. Prostate cancer DNA vaccine pVax-PSA
    637. Prostate cancer DNA vaccine rPSMAt encoding PSMA
    638. Prostate Cancer Vaccine ONY-P1
    639. Prostate Tumor Antigen-activated Autologous Dendritic Cell Vaccine
    640. PROSTVAC-Contaminated W/ BVDV
    641. PSA Prostate Cancer Vaccine
    642. PSA RNA-Pulsed Dendritic Cell Vaccine
    643. PSA-OP Peptide Vaccine
    644. PSA-PAP/KLH-pulsed Autologous Dendritic Cell Vaccine
    645. PSA/IL-2/GM-CSF Vaccine
    646. PSA/PSMA DNA Plasmid INO-5150 Vaccine
    647. PSA:154-163 Peptide Vaccine
    648. PSA:154-163(155L) Peptide Vaccine
    649. PSMA/TARP Peptide Vaccine
    650. pTVG-HP Plasmid DNA Vaccine
    651. Pulmonary BCG immunotherapy for malignant melanoma
    652. pUMVC3-hIGFBP-2 Multi-Epitope Plasmid DNA Vaccine
    653. pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine
    654. pVAXrcPSAv53l DNA Vaccine
    655. Quadrivalent Human Papillomavirus (types 6, 11, 16, 18) Recombinant Vaccine
    656. Racotumomab Vaccine
    657. RAS Peptide Cancer Vaccine
    658. RAS Peptide Cancer Vaccine TG01
    659. RASVAC-C Vaccine
    660. RASVAC-V Vaccine
    661. RCAS-Akt Vaccine
    662. RCAS-Ras Vaccine
    663. Recombinant Adenovirus 5 Encoding Tumor Necrosis Factor-related Apoptosis-Inducing Ligand Vaccine
    664. Recombinant Adenovirus-Cre Recombinase Vaccine
    665. Recombinant Adenovirus-hIFN-beta Vaccine
    666. Recombinant Adenovirus-Interferon/Syn3 Vaccine
    667. Recombinant Adenovirus-L523S Vaccine
    668. Recombinant Adenovirus-LacZ Vaccine
    669. Recombinant Adenovirus-p53 SCH-58500 Vaccine
    670. Recombinant Anti-WT1 Immunotherapeutic GSK2302024A Vaccine
    671. Recombinant Colorectal cancer antigen GA733 Vaccine
    672. Recombinant dHER2 Vaccine
    673. Recombinant DNA-L523S Vaccine
    674. Recombinant Fowlpox GM-CSF Vaccine Adjuvant
    675. Recombinant Fowlpox-B7.1 Vaccine
    676. Recombinant Fowlpox-CEA(6D)/TRICOM Vaccine
    677. Recombinant Fowlpox-gp100p209 Vaccine
    678. Recombinant Fowlpox-Mgp100 Vaccine
    679. Recombinant Fowlpox-Prostate Specific Antigen Vaccine
    680. Recombinant Fowlpox-PSA(L155)/TRICOM Vaccine
    681. Recombinant Fowlpox-TRICOM Vaccine
    682. Recombinant Fowlpox-Tyrosinase Vaccine
    683. Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine
    684. Recombinant Human Fusion Protein L19TNFalpha Vaccine
    685. Recombinant Human Hsp110-gp100 Chaperone Complex Vaccine
    686. Recombinant Human MUC1-Oxidized Polymannose-pulsed Autologous Dendritic Cell Vaccine
    687. Recombinant Human Papillomavirus Nonavalent Vaccine
    688. Recombinant Modified Vaccinia Ankara-5T4 Vaccine
    689. Recombinant NY-ESO-1 ISCOMATRIX Vaccine
    690. Recombinant NY-ESO-1 Protein vaccine adjuvanted with Imiquimod
    691. Recombinant Saccharomyces Cerevisia-CEA(610D)-Expressing Vaccine GI-6207
    692. Recombinant Vaccinia DF3/MUC1 Vaccine
    693. Recombinant Vaccinia PSA Vaccine
    694. Recombinant Vaccinia Viral Vector RO5217790 Vaccine
    695. Recombinant Vaccinia-CEA Vaccine
    696. Recombinant Vaccinia-CEA(6D)-TRICOM Vaccine
    697. Recombinant Vaccinia-gp100:209-217 Vaccine
    698. Recombinant Vaccinia-Mgp100 Vaccine
    699. Recombinant Vaccinia-MUC-1 Vaccine
    700. Recombinant Vaccinia-MUC1-B7 Vaccine
    701. Recombinant Vaccinia-Multiepitope Melanoma Peptides-B7.1-B7.2 Vaccine
    702. Recombinant Vaccinia-NY-ESO-1 Vaccine
    703. Recombinant Vaccinia-Prostate Specific Antigen Vaccine
    704. Recombinant Vaccinia-PSA/PSMA Vaccine
    705. Recombinant Vaccinia-TRP1 Vaccine
    706. Remestemcel-L Vaccine
    707. Renal Cell Carcinoma Peptides Vaccine IMA901
    708. Renal Cell Carcinoma/CD40L RNA-Transfected Autologous Dendritic Cell Vaccine AGS-003
    709. Renal Tumor-Reactive Autologous Peripheral Blood Lymphocyte Vaccine
    710. Retrovector Encoding Mutant Anti-Cyclin G1 Vaccine
    711. Retroviral Vector MFGS-MOv18-gamma Vaccine
    712. rF-MUC1(DF3)/TRICOM Vaccine
    713. rF-PSA/PSMA/TRICOM Vaccine
    714. Rilimogene-galvacirepvec Vaccine
    715. RIPO(H3.3)
    716. rMCMV-TRP2
    717. rMeV- SCD
    718. rMVTT- HPV16-E6/E7
    719. Sargramostim Plasmid DNA Melanoma Vaccine Adjuvant
    720. Sargramostim Plasmid DNA Pancreatic Tumor Cell Vaccine
    721. SCIB1 DNA vaccine
    722. secPD-L1
    723. short overlapping peptides and full-length recombinant protein
    724. Sialyl Lewis-keyhole limpet hemocyanin conjugate vaccine
    725. Sialyl Tn-KLH Vaccine
    726. Sipuleucel-T Vaccine
    727. smallpox vaccine
    728. SRL172
    729. STn-KLH plus Detox Vaccine
    730. Survivin Antigen Vaccine DPX-Survivac
    731. Survivin Sur1M2 Peptide Vaccine
    732. Survivin/p53/HER2 Antigen-loaded Autologous Dendritic Cell Vaccine
    733. SVN53-67/M57-KLH Peptide Vaccine
    734. Synchotrope TA2M Vaccine
    735. Synchrotope TA2M Plasmid DNA Vaccine
    736. Synchrovax SEM Plasmid DNA Vaccine
    737. Synthetic Breast Cancer Peptides-Tetanus Toxoid-Montanide ISA-51 Vaccine
    738. Synthetic Glioblastoma Mutated Tumor-specific Peptides Vaccine Therapy APVAC2
    739. Synthetic Glioblastoma Tumor-associated Peptides Vaccine Therapy APVAC1
    740. Synthetic hTERT DNA Vaccine INO-1400
    741. Synthetic Long E6/E7 Peptides Vaccine HPV-01
    742. Synthetic Melanoma-Associated Antigens Vaccine
    743. Synthetic MUC1 Peptide Vaccine
    744. Synthetic Peptides E-PRA And E-PSM Vaccine
    745. TARP 27-35 Peptide Vaccine
    746. TARP 29-37-9V Peptide Vaccine
    747. TBC-CEA-Contaminated W/ BVDV Vaccine
    748. Telomerase Peptide Vaccine GV1001
    749. Telomerase-specific Type 5 Adenovirus OBP-301 Vaccine
    750. Telomerase: 540-548 Peptide Vaccine
    751. Tergenpumatucel-L Vaccine
    752. Tetanus peptide melanoma vaccine
    753. Tetravalent RNA-lipoplex Cancer Vaccine
    754. TGFβ2 Antisense-GMCSF Gene Modified Autologous Tumor Cell Vaccine
    755. Therapeutic Breast/Ovarian/Prostate Peptide Cancer Vaccine DPX-0907
    756. TICE BCG
    757. TLR-9/GM Vaccine
    758. Tn(c)-KLH Conjugate Vaccine
    759. Total Tumor RNA-loaded Dendritic Cell Vaccine
    760. Transgenic Lymphocyte Immunization Vaccine
    761. TriAd Cancer Vaccine
    762. TriMixDC-MEL Vaccine
    763. TRP-2: 180-188 Peptide Vaccine
    764. TRP1(0RF3):1-9 Peptide Vaccine
    765. Tumor antigen-sensitized DC vaccine
    766. Tumor Cell Derivative Vaccine
    767. Tumor Lysate-pulsed Dendritic Cell Vaccine
    768. Tumor Lysate/KLH Pulsed Dendritic Cell Vaccine
    769. TVI-Brain-1
    770. Tyrosinase-KLH Vaccine
    771. tyrosinase240–251S, 368-376D Vaccine
    772. Unconjugated Lymphoma Ig Id Vaccine
    773. Unconjugated Myeloma Ig Id Vaccine
    774. URLC10 Peptide Vaccine
    775. URLC10-CDCA1-KOC1 Multipeptide Vaccine
    776. URLC10-TTK-KOC1-VEGFR1-VEGFR2 Multipeptide Vaccine
    777. UV1 Telomerase Peptide Vaccine
    778. vaccinia melanoma cell lysates (VMCL) Vaccine
    779. Vaccinia Melanoma Oncolysates (VMO) Vaccine
    780. Vaccinia Virus DD-CDSR Vaccine
    781. Vaccinia-GM-CSF Vaccine
    782. Vaccinia-Tyrosinase Vaccine
    783. VCL-CB01 Vaccine
    784. VEGFR-2 DNA Vaccine VXM01
    785. VEGFR1-1084 Peptide Vaccine
    786. VEGFR2-169 Peptide Vaccine
    787. Verpasep Caltespen Vaccine
    788. VHL-42: 65-76(V74G) Peptide Vaccine
    789. VHL-59: 116-128 Peptide Vaccine
    790. VHL14 Peptide Vaccine
    791. VHL16 Peptide Vaccine
    792. VHL2 (Y12M) Peptide Vaccine
    793. Vi Capsular Polysaccharide Typhoid Vaccine
    794. Viagenpumatucel-L Vaccine
    795. VMCL
    796. Von Hippel-Lindau Peptide Vaccine
    797. Whole tumor cell-based leukemia vaccine
    798. WT1 124-138 Peptide Vaccine
    799. WT1 126-134 Peptide Vaccine
    800. WT1 235-243 Peptide Vaccine
    801. WT1 247-261 Peptide Vaccine
    802. WT1 Analog Peptide Vaccine
    803. WT1 Peptide Vaccine OCV-501
    804. WT1 Peptide Vaccine WT2725
    805. WT1 Trio Peptide Vaccine
    806. WT1-A10/AS01B Immunotherapeutic GSK2130579A Vaccine
    807. XBP1-US/XBP1-SP/CD138/CS1 Multipeptide Vaccine PVX-410
    808. Xenogeneic Tyrosinase DNA Vaccine
  4. References
I. General Information
1. Disease:
Cancer
2. Introduction
Cancer is a class of diseases in which a group of cells display uncontrolled growth (division beyond the normal limits), invasion (intrusion on and destruction of adjacent tissues), and sometimes metastasis (spread to other locations in the body via lymph or blood). These three malignant properties of cancers differentiate them from benign tumors, which are self-limited, and do not invade or metastasize. Most cancers form a tumor but some, like leukemia, do not. The branch of medicine concerned with the study, diagnosis, treatment, and prevention of cancer is oncology.

Cancer affects people at all ages with the risk for most types increasing with age. Cancer caused about 13% of all human deaths in 2007 (7.6 million). Cancers are caused by abnormalities in the genetic material of the transformed cells. These abnormalities may be due to the effects of carcinogens, such as tobacco smoke, radiation, chemicals, or infectious agents. Other cancer-promoting genetic abnormalities may randomly occur through errors in DNA replication, or are inherited, and thus present in all cells from birth. The heritability of cancers is usually affected by complex interactions between carcinogens and the host's genome.

Genetic abnormalities found in cancer typically affect two general classes of genes. Cancer-promoting oncogenes are typically activated in cancer cells, giving those cells new properties, such as hyperactive growth and division, protection against programmed cell death, loss of respect for normal tissue boundaries, and the ability to become established in diverse tissue environments. Tumor suppressor genes are then inactivated in cancer cells, resulting in the loss of normal functions in those cells, such as accurate DNA replication, control over the cell cycle, orientation and adhesion within tissues, and interaction with protective cells of the immune system.

Definitive diagnosis requires the histologic examination of a biopsy specimen, although the initial indication of malignancy can be symptomatic or radiographic imaging abnormalities. Most cancers can be treated and some forced into remission, depending on the specific type, location, and stage. Once diagnosed, cancer is usually treated with a combination of surgery, chemotherapy and radiotherapy. As research develops, treatments are becoming more specific for different varieties of cancer. There has been significant progress in the development of targeted therapy drugs that act specifically on detectable molecular abnormalities in certain tumors, and which minimize damage to normal cells. The prognosis of cancer patients is most influenced by the type of cancer, as well as the stage, or extent of the disease. In addition, histologic grading and the presence of specific molecular markers can also be useful in establishing prognosis, as well as in determining individual treatments (Wiki: Cancer).
Loading...
Loading Pathogen Genes...
Loading...
Loading Host Genes...
Loading...
Loading Vaccines...
Loading References...